1991
DOI: 10.1111/j.1365-2222.1991.tb00829.x
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitory effect of inhaled procaterol on anaphylactic bronchoconstriction and thromboxane A2 production in guinea‐pigs

Abstract: This study was designed to examine whether an inhaled beta 2-agonist, procaterol, inhibits thromboxane A2 (TXA2) production induced by antigen challenge in passively sensitized guinea-pigs in vivo. Antigen-induced bronchoconstriction was markedly inhibited by pre-treatment with procaterol. Inhaled procaterol significantly reduced in a dose-dependent manner the increment in TXB2 concentration in bronchoalveolar lavage fluid obtained 5 min after antigen challenge. Aerosol administration of procaterol significant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
16
0

Year Published

1991
1991
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 22 publications
1
16
0
Order By: Relevance
“…In addition, TxA2 may, in this species, be one of the final pathways of airflow obstruction and airway plasma exudation induced by platelet activating factor (Tokuyama et al, 1991) and bradykinin Kawikova et al, 1992). In guinea-pigs, allergeninduced airflow obstruction is mediated in part via TxA2 production (Beasley et al, 1989;Arakawa et al, 1993), and an increased level of TxB2 is found in bronchoalveolar lavage after allergen challenge (Fujimura et al, 1991).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, TxA2 may, in this species, be one of the final pathways of airflow obstruction and airway plasma exudation induced by platelet activating factor (Tokuyama et al, 1991) and bradykinin Kawikova et al, 1992). In guinea-pigs, allergeninduced airflow obstruction is mediated in part via TxA2 production (Beasley et al, 1989;Arakawa et al, 1993), and an increased level of TxB2 is found in bronchoalveolar lavage after allergen challenge (Fujimura et al, 1991).…”
Section: Introductionmentioning
confidence: 99%
“…The resulting ID 50 or IC 50 values showed that cilostazol powder was somewhat less inhibitory regarding antigen–induced bronchoconstriction than histamine–induced bronchoconstriction (ID 50 of 60.4µg against antigen vs. 7.0 µg against histamine), while KF19514 solution was more active against antigen–induced bronchoconstriction than against histamine–induced bronchoconstriction (IC 50 of 0.40 against antigen vs. 2.81 µg/ml against histamine). The inhibitory effects of cilostazol and KF–19514 against histamine–induced bronchoconstriction are relatively weak compared with that of a β 2 –agonist procaterol with an IC 50 of less than 0.5 µg/ml previously shown by us [28]. …”
Section: Discussionmentioning
confidence: 99%
“…Since Pao increased immediately after antigen and histamine inhalation and the bronchodilator procaterol almost completely inhibited the increases in Pao [28], it is likely that the increase in Pao is indicative of bronchoconstriction in our experimental system.…”
Section: Discussionmentioning
confidence: 99%
“…Since Pao increased immediately after antigen and histamine inhalation and the bronchodilator procaterol almost completely inhibited the increases in Pao [17], it is likely that the increase in Pao is indicative of bronchoconstriction in our experimental system.…”
Section: Discussionmentioning
confidence: 99%